药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Bromo-2,5-dimethoxyamphetamine
7,9-Dimethylguanine
The metabolism of 7,9-Dimethylguanine can be decreased when combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
8-azaguanine
The metabolism of 8-azaguanine can be decreased when combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Terodiline
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Terodiline.
4-Bromo-2,5-dimethoxyamphetamine
Macimorelin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Macimorelin.
4-Bromo-2,5-dimethoxyamphetamine
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Deutetrabenazine.
4-Bromo-2,5-dimethoxyamphetamine
Glasdegib
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Glasdegib.
4-Bromo-2,5-dimethoxyamphetamine
Ribociclib
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ribociclib.
4-Bromo-2,5-dimethoxyamphetamine
Ivabradine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ivabradine.
4-Bromo-2,5-dimethoxyamphetamine
Lumefantrine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Lumefantrine.
4-Bromo-2,5-dimethoxyamphetamine
Artemether
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Artemether.
4-Bromo-2,5-dimethoxyamphetamine
Asenapine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Asenapine.
4-Bromo-2,5-dimethoxyamphetamine
Iloperidone
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Iloperidone.
4-Bromo-2,5-dimethoxyamphetamine
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Tetrabenazine.
4-Bromo-2,5-dimethoxyamphetamine
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Zuclopenthixol.
4-Bromo-2,5-dimethoxyamphetamine
Berotralstat
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Berotralstat.
4-Bromo-2,5-dimethoxyamphetamine
Encorafenib
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Encorafenib.
4-Bromo-2,5-dimethoxyamphetamine
Ivosidenib
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ivosidenib.
4-Bromo-2,5-dimethoxyamphetamine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dexverapamil.
4-Bromo-2,5-dimethoxyamphetamine
Penfluridol
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Penfluridol.
4-Bromo-2,5-dimethoxyamphetamine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dexchlorpheniramine.